ICMR Registration No: SHMTL Mc-3912: Quality Healthcare Is A Human Right

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Quality healthcare is a human right ICMR Registration

No : SHMTL MC-3912

TESTING LAB
GISPL.ML1
(820610)
Azadpur, New
Delhi

Patient ID: SH1534431 Sample ID: 0707700740541


Name: GAURABMV Sample Collected: 27/03/2021 (Pre-Collected Sample)

Address: KASHMERE GATE DELHI


Sample Received: 27/03/2021 17:05
PIN:,CENTRAL, Age: 25 YEARS, Gender:
Report Generated: 29/03/2021 18:43
MALE
Report Status: FINAL
Mobile Number: 7428803203

TEST REPORT

Test Method SARS CoV-2 Qualitative

RT PCR Specimen Type Nasopharyngeal

& Oropharyngeal

Gene 1: ORF1ab NA

Gene 2: N NA

Result Negative

INTERPRETATION

RESULT REMARKS

Positive RNA Specific To SARS-COV-2 Detected

Negative RNA Specific To SARS-COV-2 Not Detected

Inconclusive A Repeat Sample Is Suggested In Case Of Clinical Suspicion

Non Diagnostic Internal control not detected, samples need to be repeated

ABOUT SARS COV 2 LIMITATIONS


SARSCoV2, formerly known as 2019nCoV, is the causative agent of the 1. Negative results do not preclude COVID19 and should not be used as the
coronavirus disease 2019 (COVID19). Main symptoms of the disease sole basis for patient management decisions. Negative results must be
include fever, cough and shortness of breath. The virus is spread via combined with clinical observations, patient history, and epidemiological
persontoperson contact through respiratory droplets produced when a information.
person coughs or sneezes. The SARSCoV2 2. Positive results but do not rule out bacterial infection or coinfection
RNA is generally detectable in nasopharyngeal/oropharyngeal swabs with other viruses.
during the acute phase of infection. Positive results are indicative of 3. Optimum specimen types and timing for peak viral levels during
active infection. Real Time PCR assay targets specific genes and can be infections caused by 2019nCoV have not been determined. Collection of
used for diagnosis of SARSCoV2 virus infection which contributes to multiple specimens (types and time points) from the same patient may be
severe upper respiratory distress, complications necessary to detect the virus.
4. If the virus mutates in the rRTPCR target region, 2019nCoV may not be
detected or may be detected less predictably. Inhibitors or other types of
interference may produce a false negative result.
5. The performance of this test has not been established for monitoring
treatment of
2019nCoV infection.

Dr Neha Kaushal Dr. Ruchika Manchanda


Consultant Laboratory Director
Microbiologist

REFERENCES
1. Laboratory testing for coronavirus disease 2019 (COVID19) in suspected human cases. Interim guidance. World Health Organization.
2. Druce et al. JCM. 2011
3. N. Engl. J. Med. 2020, 382, 929–936

*DISCLAIMERS
1. This is only a professional opinion. Not for Medico legal purpose.
2. Please correlate clinically.
SPICE HEALTHCARE PRIVATE
LIMITED
Corporate Office: 320, Udyog Vihar - 4, Gurgaon, Haryana | CIN:
U33100DL2018PTC333650
Telephone No.: +91-96432-26600 | Website: www.spicehealth.com | Email ID:
[email protected]

------------------------- End of Report -------------------------

You might also like